Marker Therapeutics, Inc. (MRKR)
NASDAQ·Healthcare·Biotechnology
$1.43
-1.38%
Mkt Cap $15.87M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $682.10K | $1.10M | +61.27% | -$0.21 | -$0.04 | +80.95% | — | — |
| Q4 2025 Nov 13, 2025 | $723.00K | $1.23M | +70.53% | -$0.36 | -$0.12 | +66.67% | — | — |
| Q3 2025 Aug 14, 2025 | $430.60K | $861.18K | +100.00% | -$0.30 | -$0.29 | +4.56% | — | — |
| Q2 2025 May 21, 2025 | $174.55K | $349.10K | +100.00% | -$0.66 | -$0.27 | +59.09% | — | — |
| Q1 2025 Mar 31, 2025 | $1.22M | $2.25M | +84.10% | -$0.22 | -$0.42 | -90.91% | — | — |
| Q4 2024 Nov 14, 2024 | $1.00M | $1.93M | +92.60% | -$0.39 | -$0.26 | +33.33% | — | — |
| Q3 2024 Aug 14, 2024 | — | $1.17M | — | -$0.43 | -$0.29 | +32.56% | — | — |
| Q2 2024 May 15, 2024 | — | $1.24M | — | -$0.25 | -$0.27 | -8.00% | — | — |
| Q1 2024 Mar 26, 2024 | — | $1.06M | — | -$1.00 | -$0.48 | +52.00% | — | — |
| Q4 2023 Nov 9, 2023 | — | $257.61K | — | -$0.90 | -$0.34 | +62.22% | — | — |
| Q3 2023 Aug 14, 2023 | — | $762.66K | — | -$0.80 | -$0.47 | +41.25% | — | — |
| Q2 2023 May 16, 2023 | — | $1.23M | — | $0.80 | -$0.57 | -171.25% | — | — |
| Q1 2023 Mar 22, 2023 | $270.00K | $759.14K | +181.16% | -$1.00 | -$0.48 | +52.00% | — | — |
| Q4 2022 Nov 10, 2022 | $400.00K | $999.57K | +149.89% | -$1.20 | -$0.80 | +33.33% | — | — |
| Q3 2022 Aug 11, 2022 | $2.50M | $790.51K | -68.38% | -$1.27 | -$1.10 | +13.39% | — | — |
| Q2 2022 May 13, 2022 | $1.00M | $964.32K | -3.57% | -$1.33 | -$1.20 | +9.77% | — | — |
| Q1 2022 Mar 17, 2022 | — | $1.24M | — | -$1.27 | -$1.20 | +5.51% | — | — |
| Q4 2021 Nov 10, 2021 | — | — | — | -$1.27 | -$1.20 | +5.51% | — | — |
| Q3 2021 Aug 10, 2021 | — | — | — | -$1.17 | -$1.30 | -11.11% | — | — |
| Q2 2021 May 12, 2021 | — | — | — | -$1.45 | -$1.60 | -10.34% | — | — |